therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes

MLA

Jonathan Perkins, et al. “TherascreenPITX2 RGQ PCR Assay for the Assessment of PITX2 DNA-Methylation Status to Investigate the Role of the Transcription Factor PITX2 and the Regulation of the Wnt/ß-Catenin Pathway in Pathophysiological Processes.” Protocol Exchange, Feb. 2018. EBSCOhost, https://doi.org/10.1038/protex.2018.022.

APA

Jonathan Perkins, Rudolf Napieralski, Gabriele Schricker, Elodie Piednoir, Olivia Manner, Alexandre Bona, Samantha Segalas, Elisabeth Schueren, Juergen Lauber, Aurelia Noske, Viktor Magdolen, Wilko Weichert, Marion Kiechle, Olaf Wilhelm, & Manfred Schmitt. (2018). therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes. Protocol Exchange. https://doi.org/10.1038/protex.2018.022

Chicago

Jonathan Perkins, Rudolf Napieralski, Gabriele Schricker, Elodie Piednoir, Olivia Manner, Alexandre Bona, Samantha Segalas, et al. 2018. “TherascreenPITX2 RGQ PCR Assay for the Assessment of PITX2 DNA-Methylation Status to Investigate the Role of the Transcription Factor PITX2 and the Regulation of the Wnt/ß-Catenin Pathway in Pathophysiological Processes.” Protocol Exchange, February. doi:10.1038/protex.2018.022.